CapEx at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s capex?
- Bio-Rad Laboratories, Inc. (BIO.B) reported capex of $30M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s capex changed year-over-year?
- Bio-Rad Laboratories, Inc.'s capex decreased by 12.8% year-over-year, from $34.4M to $30M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s capex?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s capex has grown at a 4.2% compound annual growth rate (CAGR), from $133.75M to $157.6M.
- What does capex mean?
- Cash spent on purchasing or upgrading long-term physical assets.
- How do you interpret capex?
- High levels indicate aggressive growth or modernization, while low levels may suggest a focus on cash preservation or a mature asset base.
- How does capex compare across companies?
- Varies by industry lifecycle; capital-intensive manufacturing peers typically have higher capital expenditure requirements than software peers.